Frederick Financial Consultants’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
USCWA
NA
SPIA
RA
WIA
Frederick Financial Consultants's REVS Position: Q1 2026 in Review
Frederick Financial Consultants reduced its Columbia Research Enhanced Value ETF (REVS) stake by 0.38% in Q1 2026, selling an estimated $2.88K and leaving 26,300 shares worth $753K. The position accounts for 0.37% of the portfolio, ranked #47.
Frederick Financial Consultants first reported a position in REVS in Q4 2024 and has held it in 6 quarters since. The position peaked at $965K in Q4 2024. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.
- Frederick Financial Consultants held 26,300 shares of Columbia Research Enhanced Value ETF worth $753K as of Q1 2026.
- Frederick Financial Consultants sold 99 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $2.88K.
- Columbia Research Enhanced Value ETF made up 0.37% of Frederick Financial Consultants's portfolio in Q1 2026, its #47 holding.
- Frederick Financial Consultants first reported a position in Columbia Research Enhanced Value ETF in Q4 2024 and has held it in 6 quarters since.
- Frederick Financial Consultants's Columbia Research Enhanced Value ETF position peaked at $965K in Q4 2024.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.
Based on Frederick Financial Consultants's 13F filing for Q1 2026, filed 14 May 2026.